Firms
Theme

AME

Ametek, Inc. · NYSE

News

3 latest

Zacks Investment Research

Why Ametek (AME) Could Beat Earnings Estimates Again

Ametek (AME), an electronics testing equipment manufacturer, is highlighted as a strong candidate for beating upcoming earnings estimates. The company has a track record of beating consensus estimates with an average surprise of 4.35% over the past two quarters and currently holds a positive Earnings ESP of +0.90% combined with a Zacks Rank #2 (Buy) rating, suggesting a high probability of another earnings beat.

Zacks Investment Research

All You Need to Know About Ametek (AME) Rating Upgrade to Buy

Ametek (AME) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates over the past three months. The upgrade positions the company in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving business fundamentals and institutional investor buying pressure.

Mentions AME

Zacks Investment Research

Roper Technologies Set to Report Q3 Earnings: What's in the Cards?

Roper Technologies is set to report Q3 2026 results on October 22 with expected revenues of $2.18 billion (7.9% growth) and adjusted EPS of $5.79 (12.7% growth). The company's Application Software, Network Software, and Technology Enabled Products segments are anticipated to show strength driven by SaaS adoption, GenAI innovation, and the Subsplash acquisition. However, rising operating costs and foreign exchange headwinds pose challenges to profitability.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AME · 0 threads

Sign in to post on $AME

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev